Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease

Clinical trial NCT02770625 · COMPLETED

Trial details

NCT number: NCT02770625
Sponsor: ISU Abxis Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gaucher Disease, Type 1

Start date: 2011-09-01
Primary completion: 2013-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.